Definitive Healthcare (NASDAQ:DH) Releases Q2 2024 Earnings Guidance

Definitive Healthcare (NASDAQ:DH) updated its second quarter 2024 earnings guidance on Wednesday. The company provided earnings per share guidance of 0.080-0.090 for the period, compared to the consensus earnings per share estimate of 0.090. The company issued revenue guidance of $62.0 million-$63.5 million, compared to the consensus revenue estimate of $65.2 million. Definitive Healthcare also updated its FY 2024 guidance to 0.360-0.380 EPS.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on DH shares. Barclays decreased their target price on Definitive Healthcare from $11.00 to $7.00 and set an equal weight rating for the company in a research report on Thursday. Deutsche Bank Aktiengesellschaft decreased their price objective on Definitive Healthcare from $10.00 to $7.00 and set a hold rating for the company in a research report on Thursday. Needham & Company LLC reissued a hold rating on shares of Definitive Healthcare in a research report on Wednesday. Canaccord Genuity Group decreased their price target on shares of Definitive Healthcare from $10.00 to $8.00 and set a hold rating for the company in a report on Wednesday. Finally, Morgan Stanley lowered shares of Definitive Healthcare from an overweight rating to an equal weight rating and dropped their price objective for the company from $11.50 to $9.00 in a research note on Wednesday. Nine equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat, Definitive Healthcare has an average rating of Hold and a consensus price target of $9.94.

Definitive Healthcare Stock Down 3.4 %

Shares of DH stock traded down $0.18 on Thursday, hitting $5.17. The company’s stock had a trading volume of 3,323,524 shares, compared to its average volume of 643,916. The company has a debt-to-equity ratio of 0.20, a current ratio of 2.31 and a quick ratio of 2.31. The stock has a market capitalization of $608.97 million, a price-to-earnings ratio of -2.90, a P/E/G ratio of 6.12 and a beta of 1.41. Definitive Healthcare has a fifty-two week low of $4.38 and a fifty-two week high of $12.45. The firm’s fifty day moving average price is $7.61 and its 200-day moving average price is $8.27.

Definitive Healthcare (NASDAQ:DH) last released its quarterly earnings results on Wednesday, February 28th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.01 by ($0.02). Definitive Healthcare had a positive return on equity of 0.43% and a negative net margin of 80.40%. The company had revenue of $65.93 million for the quarter, compared to the consensus estimate of $66.01 million. Research analysts anticipate that Definitive Healthcare will post 0.11 EPS for the current year.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.